Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Viridian Therapeutics Inc. buy DomRuinart

Viridian Therapeutics Inc.
Start price
€20.60
01.10.24 / 50%
Target price
€22.00
01.10.25
Performance (%)
3.88%
End price
€21.40
14.10.24
Summary
This prediction ended on 14.10.24 with a price of €21.40. The BUY prediction by DomRuinart finished with a performance of 3.88%. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Viridian Therapeutics Inc. - - -
iShares Core DAX® 0.437% 5.897% 8.047%
iShares Nasdaq 100 1.057% 0.920% 28.466%
iShares Nikkei 225® 1.769% 1.228% 47.574%
iShares S&P 500 0.368% 1.920% 23.200%

According to DomRuinart what are the pros and cons of Viridian Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by DomRuinart for this prediction

In the thread Viridian Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 3.88%
Target price 22.000
Change
Ends at

Buy mit Kursziel 22,0

DomRuinart 
0
Report Share
01.10.24
In the thread Trading Viridian Therapeutics Inc.
Prediction Buy
Perf. (%) 3.88%
Target price 22.000
Change
Ends at 01.10.25

Buy beendet

DomRuinart 
0
Report Share
14.10.24